Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner

Aisha Masood, Kasyapa Chitta, Aneel Paulus, A. Nazmul H. Khan, Taimur Sher, Noreen Ersing, Kena C. Miller, Deborah Manfredi, Sikander Ailawadhi, Ivan Borrelo, Kelvin P. Lee, Asher A. Chanan-Khan

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner'. Together they form a unique fingerprint.

Medicine & Life Sciences